Health Canada Grants Neuralink Implant Approval
The Facts
Neuralink, the Elon Musk-owned brain-implant company, has announced it received approval for the first time from Health Canada to recruit volunteers to participate in its CAN-PRIME Study, which will evaluate the safety of the implant and surgical robot, as well as determine the effectiveness of the brain-computer interface (BCI).
In this study, Neuralink says a small, unnoticeable implant will be inserted in the part of the brain that controls movements. If successful, the implant would allow a person with limited or no ability to use both hands to operate a computer or smartphone with his or her thoughts.
The Spin
Musk's Neuralink keeps breaking barriers the way his companies have in other fields. The first brain implant patient has been doing well after some early adversity, and now Neuralink is expanding its research north of the border. Neuralink has succeeded in changing the world despite US regulators trying to do what they do best — rain on an innovative company's parade.
While Neuralink may in fact change the world in a big way — especially for those who've lost use of their limbs — it's important to remember that rushing toward a goal could lead to unnecessary negative consequences. Musk would be wise to not rush forward too fast, lest Neuralink have to deal with tragedy before it achieves its desired glory.
